Mutations of Chromatin and its Modifying Machineries in Malignancies

恶性肿瘤中染色质及其修饰机制的突变

基本信息

  • 批准号:
    10224897
  • 负责人:
  • 金额:
    $ 91.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-13 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Our studies have focused on the characterization of the molecular functions and biochemical properties of the Set1/MLL family of proteins and how their chimeras and mutations are associated with childhood leukemia and other forms of cancer. We have also focused on the role of chromatin and transcriptional elongation machinery in the regulation of developmental gene expression and how the misregulation of their activities is associated with malignancies. Our hope is that our molecular studies will advance our understanding of the molecular mechanisms of rearrangement-based and mutation-based cancer through the epigenetic regulators. Our biochemical and molecular studies demonstrated that Set1 in yeast exists in the Set1/COMPASS complex capable of methylating lysine 4 of histone H3 (H3K4). We demonstrated that Drosophila cells possess three Set1-related proteins and mammalian cells have six Set1-related proteins all found within COMPASS-like compositions capable of methylating histone H3K4. Furthermore, given that there is almost no sequence homology between many of the MLL translocation partners, for many years, it was unclear why MLL translocations into so many unrelated genes result in the pathogenesis of leukemia. Our biochemical studies on the purification of the MLL-chimeras demonstrated that many of the MLL translocation partners are part of the same macromolecular complex we named the Super Elongation Complex (SEC). We demonstrated that the translocations of MLL within any of the subunits of SEC subunits result in the misrecruitment of SEC to the MLL target genes and in the perturbation of the transcriptional checkpoint control of these genes, triggering leukemic growth. Additionally, the recent cataloging of somatic mutations in cancer identified a large number of mutations in the components of the MLL1-4 and Set1A/B complexes in both hematological malignancies and solid tumors. However, we know very little why the COMPASS family is mutated in different cancers. Given that we have developed a fantastic set of reagents and tools over the past seventeen years towards these factors and their associated proteins, chromatin, and other chromatin modifiers in multiple model systems; my laboratory is in a very unique position to define the molecular bases of these factors' involvement in cancer pathogenesis for the purpose of targeted therapeutics. Therefore, the goals of this R35 application is the full molecular and biochemical characterization of the COMPASS family, the translocation partners within the Super Elongation Complex (SEC), and the role of chromatin itself in the regulation of gene expression and development, and how their mutations contribute to the pathogenesis of human cancer.
 描述(由申请人提供):我们的研究集中在Set 1/MLL蛋白家族的分子功能和生化特性的表征以及它们的嵌合体和突变如何与儿童白血病和其他形式的癌症相关。我们还关注了染色质和转录延伸机制在发育基因表达调控中的作用,以及它们的活性失调如何与恶性肿瘤相关。我们的希望是,我们的分子研究将通过表观遗传调节因子促进我们对基于重复和基于突变的癌症的分子机制的理解。我们的生物化学和分子生物学研究表明,酵母中的Set 1存在于Set 1/COMPASS复合物中,能够甲基化组蛋白H3的赖氨酸4(H3 K4)。我们证明,果蝇细胞具有三个Set 1相关的蛋白质和哺乳动物细胞有六个Set 1相关的蛋白质都发现在COMPASS样组合物能够甲基化组蛋白H3 K4。此外,鉴于许多MLL易位伴侣之间几乎没有序列同源性,多年来,尚不清楚为什么MLL易位到如此多的不相关基因中导致白血病的发病机制。我们对MLL-嵌合体纯化的生物化学研究表明,许多MLL易位伴侣是我们命名为超延伸复合物(SEC)的相同大分子复合物的一部分。我们证明了MLL在SEC亚基的任何亚基内的易位导致SEC向MLL靶基因的错误募集以及这些基因的转录检查点控制的扰动,从而触发白血病生长。此外,最近对癌症中体细胞突变的分类鉴定了血液恶性肿瘤和实体瘤中MLL 1 -4和Set 1A/B复合物组分中的大量突变。然而,我们对COMPASS家族在不同癌症中发生突变的原因知之甚少。鉴于我们在过去的十七年中已经开发了一套非常棒的试剂和工具,用于多模型系统中的这些因子及其相关蛋白质,染色质和其他染色质修饰剂;我的实验室处于一个非常独特的位置,可以定义这些因子参与癌症发病机制的分子基础,以实现靶向治疗的目的。因此,该R35应用的目标是COMPASS家族的完整分子和生物化学表征,超级延伸复合物(SEC)内的易位伴侣,染色质本身在基因表达和发育调控中的作用,以及它们的突变如何有助于人类癌症的发病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ali Shilatifard其他文献

Ali Shilatifard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ali Shilatifard', 18)}}的其他基金

Epigenetics, Metabolism and Cancer
表观遗传学、新陈代谢和癌症
  • 批准号:
    10712221
  • 财政年份:
    2023
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    10705758
  • 财政年份:
    2015
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    9126472
  • 财政年份:
    2015
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    9754580
  • 财政年份:
    2015
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    10518587
  • 财政年份:
    2015
  • 资助金额:
    $ 91.97万
  • 项目类别:
The COMPASS family of H3K4 methylases in development and cancer
H3K4 甲基化酶 COMPASS 家族在发育和癌症中的作用
  • 批准号:
    8759914
  • 财政年份:
    2010
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8403710
  • 财政年份:
    2010
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8595296
  • 财政年份:
    2010
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8204739
  • 财政年份:
    2010
  • 资助金额:
    $ 91.97万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8041000
  • 财政年份:
    2010
  • 资助金额:
    $ 91.97万
  • 项目类别:

相似海外基金

Nonlocal Variational Problems from Physical and Biological Models
物理和生物模型的非局部变分问题
  • 批准号:
    2306962
  • 财政年份:
    2023
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Standard Grant
Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
即时光学光谱平台和新颖的比率度量算法,可快速、系统地表征体内生物模型的功能
  • 批准号:
    10655174
  • 财政年份:
    2023
  • 资助金额:
    $ 91.97万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2022
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Discovery Grants Program - Individual
Micro-electrofluidic platforms for monitoring 3D human biological models
用于监测 3D 人体生物模型的微电流体平台
  • 批准号:
    DP220102872
  • 财政年份:
    2022
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Discovery Projects
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2021
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Discovery Grants Program - Individual
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2020
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Discovery Grants Program - Individual
Harnessing machine learning and cloud computing to test biological models of the role of white matter in human learning
利用机器学习和云计算来测试白质在人类学习中的作用的生物模型
  • 批准号:
    2004877
  • 财政年份:
    2020
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Fellowship Award
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9899988
  • 财政年份:
    2019
  • 资助金额:
    $ 91.97万
  • 项目类别:
Multi-scale stochastic systems motivated by biological models
由生物模型驱动的多尺度随机系统
  • 批准号:
    RGPIN-2015-06573
  • 财政年份:
    2019
  • 资助金额:
    $ 91.97万
  • 项目类别:
    Discovery Grants Program - Individual
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
便携式低成本调查点 CapCell 示波器,用于对体外和体内生物模型中的主要代谢轴和相关脉管系统进行成像和量化
  • 批准号:
    9753458
  • 财政年份:
    2019
  • 资助金额:
    $ 91.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了